Conference Call with Dr. Lal Pathlabs Management and Analysts on Q1FY25 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Dr. Lal Pathlabs announced Q1FY25 results: Revenue increased by 11.3% in Q1FY25 to Rs 602 crore EBITDA increased by 16.2% with a margin of 28.2% PAT increased by 29.1% to Rs 108 crore with a margin for of 17.9% Interim Dividend of Rs 6 per share for FY 2024-25 Result PDF